Phase II study of paclitaxel and gemcitabine in advanced non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Lazaro, M [1 ]
Jorge, M [1 ]
Castellanos, J [1 ]
机构：
[1] Hosp Xeral Cies, Dept Med Oncol, Vigo, Spain
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
493P
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [21] Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer
    Chen, YM
    Perng, RP
    Whang-Peng, J
    Wu, HW
    Lin, WC
    Tsai, CM
    LUNG CANCER, 2000, 30 (03) : 199 - 202
  • [22] Gemcitabine, ifosfamide and vinorelbine in advanced non-small cell lung cancer: A phase II study
    Recchia, F
    Lombardo, M
    De Filippis, S
    Rosselli, M
    Rea, S
    ANTICANCER RESEARCH, 2002, 22 (2B) : 1321 - 1328
  • [23] Phase II study of regimen of gemcitabine and cisplatin in advanced non-small cell lung cancer
    Chen, SCH
    Lin, MC
    Chang, JWC
    Wang, SW
    Lee, CH
    Tsao, TCY
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2000, 30 (11) : 494 - 498
  • [24] Paclitaxel, cisplatin and gemcitabine combination chemotherapy in stage IV non-small cell lung cancer (NSCLC):: A phase II study.
    Cortes, J
    Rodriguez, J
    Calvo, E
    Martinez-Monge, R
    Fernández-Hildago, O
    Garzón, C
    Santisteban, M
    de Irala, J
    Azinovic, I
    Brugarolas, A
    ANNALS OF ONCOLOGY, 2000, 11 : 118 - 118
  • [25] Concurrent chemoradiotherapy with Gemcitabine for locally advanced non-small cell lung cancer (NSCLC): Preliminary results of a phase II study
    Athanasiou, E
    Cyrgias, G
    Boinis, K
    Samantas, E
    Christodoulidou, M
    Tamvaki, F
    Panoussaki, E
    ANNALS OF ONCOLOGY, 1998, 9 : 97 - 97
  • [26] A multicenter phase II study of induction chemotherapy with gemcitabine and carboplatin in locally advanced non-small cell lung cancer (NSCLC)
    Aerts, Joachim G.
    van Klaveren, Rob J.
    Surmont, Veerle
    Senan, Suresh
    Tan, Yoeke
    Vernhout, Rene
    van Wijhe, Gerda
    Verhoeven, Gert T.
    Hoogsteden, Henk C.
    van Meerbeeck, Jan P.
    ANNALS OF ONCOLOGY, 2004, 15 : 174 - 175
  • [27] Phase II study of carboplatin and weekly paclitaxel in advanced non-small cell lung cancer
    Nakadate, Megumi
    Yamazaki, Koichi
    Konishi, Jun
    Kinoshita, Ichiro
    Sukoh, Noriaki
    Harada, Masao
    Akie, Kenji
    Ogura, Shigeaki
    Ishida, Takashi
    Munakata, Mitsuru
    Dosaka-Akita, Hirotoshi
    Isobe, Hiroshi
    Nishimura, Masaharu
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3767 - 3772
  • [28] A phase I trial of paclitaxel, carboplatin, and gemcitabine in advanced non-small cell lung cancer
    Kelly, K
    Prindiville, S
    Bunn, PA
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 74 - 74
  • [29] A phase II study of weekly oral paclitaxel (Paxoral®) with cyclosporin A (CsA) for advanced non-small cell lung cancer (NSCLC).
    Baas, P
    Mezger, J
    Scheulen, ME
    Keilholz, U
    Kruijtzer, CM
    Marcus, S
    Vermorken, JB
    Schellens, JH
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3743S - 3743S
  • [30] Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC):: a phase I trial
    Krajnik, G
    Wein, W
    Greil, R
    Marhold, F
    Mohn-Staudner, A
    Kummer, F
    Malayeri, R
    Zöchbauer-Müller, S
    Huber, H
    Pirker, R
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (12) : 1977 - 1980
12345